Hala El-Zimaity
Overview
Explore the profile of Hala El-Zimaity including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El-Zimaity H, Shaffer S, Riddell R, Pai R, Bernstein C
J Crohns Colitis
. 2022 Nov;
17(5):767-776.
PMID: 36426876
Background And Aims: This study examines colonic histological features in ulcerative colitis [UC] in endoscopic remission to determine which cell types and biopsy sites best predict a patient's likelihood of...
2.
Haddad T, Lugli A, Aherne S, Barresi V, Terris B, Bokhorst J, et al.
Virchows Arch
. 2021 Mar;
479(3):459-469.
PMID: 33650042
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of...
3.
El-Zimaity H, Riddell R
Histopathology
. 2020 Dec;
78(1):48-69.
PMID: 33382486
In daily practice, the presence of inflammation in gastric biopsies prompts a mental algorithm, an early question being whether the lesion present is Helicobacter-associated. If Helicobacter organisms are not found,...
4.
Cheung C, Barnes P, Bigras G, Boerner S, Butany J, Calabrese F, et al.
Appl Immunohistochem Mol Morphol
. 2019 Oct;
27(10):699-714.
PMID: 31584451
Since 2014, programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) checkpoint inhibitors have been approved by various regulatory agencies for the treatment of multiple cancers including melanoma,...
5.
El-Zimaity H, Choi W, Lauwers G, Riddell R
Virchows Arch
. 2018 Sep;
473(5):533-550.
PMID: 30255340
Gastric biopsies are often submitted with as clinical question Helicobacter pylori (HP) infection. Regularly, the morphology suggests a HP infection but the organism is not detected in special stains. This...
6.
El-Zimaity H, Di Pilato V, Ringressi M, Brcic I, Rajendra S, Langer R, et al.
Ann N Y Acad Sci
. 2018 Jun;
1434(1):319-332.
PMID: 29851130
Risk factors for esophageal cancer include genetic factors (such as tylosis) and infectious agents. A variety of organisms have been implicated in esophageal carcinogenesis, either directly or indirectly. In this...
7.
Moawad F, Cheng E, Schoepfer A, Al-Haddad S, Bellizzi A, Dawson H, et al.
Ann N Y Acad Sci
. 2016 Jul;
1380(1):204-217.
PMID: 27467185
Eosinophilic esophagitis (EoE) is a chronic antigen-mediated immune disease of the esophagus characterized by symptoms related to esophageal dysfunction, as well as significant esophageal eosinophilia. Although dense eosinophilia is the...
8.
Dodbiba L, Teichman J, Fleet A, Thai H, Starmans M, Navab R, et al.
PLoS One
. 2015 Apr;
10(3):e0121872.
PMID: 25826681
The high morbidity and mortality of patients with esophageal (E) and gastro-esophageal junction (GEJ) cancers, warrants new pre-clinical models for drug testing. The utility of primary tumor xenografts (PTXGs) as...
9.
Cheung C, Banerjee D, Barnes P, Berendt R, Butany J, Canil S, et al.
Am J Clin Pathol
. 2014 Oct;
142(5):629-33.
PMID: 25319977
Objectives: Formalin-fixed, paraffin-embedded unstained archived diagnostic tissue sections are frequently exchanged between clinical laboratories for immunohistochemical staining. The manner in which such sections are prepared represents a type of preanalytical...
10.
Al-Haddad S, El-Zimaity H, Hafezi-Bakhtiari S, Rajendra S, Streutker C, Vajpeyi R, et al.
Ann N Y Acad Sci
. 2014 Oct;
1325:187-96.
PMID: 25266025
The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on infection and cancer, and includes commentaries on the influence of bacterial infections on mucin expression...